Skip to content
2000
image of Colorectal Cancer Screening Modalities Among Saudi Population: Significant Predictors

Abstract

Introduction

Understanding the public perception of colorectal cancer screening is crucial since early diagnosis lowers mortality rates associated with this type of cancer.

Methods

The purpose of this study was to determine the most popular technique for colorectal cancer screening in Saudi Arabia. From September 2021 to February 2022, a cross-sectional study on adult Saudi population was undertaken. Data were collected through a self-created survey distributed an online platform.

Results

Out of 10,781 participants analyzed, 5,612 were found suitable for evaluating preferences between colonoscopy and fecal immunochemical test (FIT) as screening modalities. It was found that gender, employment, and age were important predictors for the preferred screening modality.

Discussion

The patient’s perspective on screening modalities is crucial to consider in national colorectal cancer screening programs. The future outlook for home-based fecal immunochemical Tests (FIT) may provide superior research regarding cost-effectiveness and adherence among patients compared to colonoscopy or medical facilities in FIT investigations.

Conclusion

More attention should be paid to the population’s preferred method of colorectal cancer screening, which could increase the success of the screening effort. Cultural and socioeconomic status might affect the generalizability of the study.

© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode.
Loading

Article metrics loading...

/content/journals/rrct/10.2174/0115748871335743250417103659
2025-05-05
2025-09-15
Loading full text...

Full text loading...

/deliver/fulltext/rrct/10.2174/0115748871335743250417103659/BMS-RRCT-2024-63.html?itemId=/content/journals/rrct/10.2174/0115748871335743250417103659&mimeType=html&fmt=ahah

References

  1. Hossain M.S. Karuniawati H. Jairoun A.A. Urbi Z. Ooi D.J. John A. Lim Y.C. Kibria K.M.K. Mohiuddin A.K.M. Ming L.C. Goh K.W. Hadi M.A. Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 2022 14 7 1732 10.3390/cancers14071732 35406504
    [Google Scholar]
  2. Zacharakis G Almasoud A Arahmaner O Aldossary K Alzahrani J Al-Ghamdi S A 5-year evaluation of early-and late-onset sporadic colorectal cancer screening in central Saudi Arabia. Saudi J. Gastroenterol. 2023 29 2 95 101 10.4103/sjg.sjg_333_22
    [Google Scholar]
  3. Alzahrani K.M. Fallatah S.M. Almehmadi R.A. Alghamdi J.S. Alsulaimani A.I. Alkhaldi L.M. Alsuwayhi A.G. Colorectal cancer and its screening among public in the western region of saudi arabia. Cureus 2022 14 7 e27404 10.7759/cureus.27404 36046279
    [Google Scholar]
  4. Alyabsi M. Algarni M. Alshammari K. Trends in colorectal cancer incidence rates in Saudi Arabia (2001–2016) using Saudi national registry: Early- versus late-onset disease. Front. Oncol. 2021 11 730689 10.3389/fonc.2021.730689 34568065
    [Google Scholar]
  5. Maes-Carballo M. García-García M. Gómez-Fandiño Y. Estrada-López C.R. Iglesias-Álvarez A. Bueno-Cavanillas A. Khan K.S. Systematic review of shared decision-making in guidelines about colorectal cancer screening. Eur. J. Cancer Care 2022 31 6 e13738 10.1111/ecc.13738 36254840
    [Google Scholar]
  6. Jiang H. Zhang P. Gu K. Gong Y. Peng P. Shi Y. Ai D. Chen W. Fu C. Cost-effectiveness analysis of a community-based colorectal cancer screening program in Shanghai, China. Front. Public Health 2022 10 986728 10.3389/fpubh.2022.986728 36276354
    [Google Scholar]
  7. Flanagan C.A. Rutten F.L.J. Kisiel J.B. Lent J.K. Bachtold J.F. Swartz A.W. Redwood D.G. Development of a colorectal cancer screening intervention for Alaska native people during a pandemic year. Contemp. Clin. Trials Commun. 2022 30 101016 10.1016/j.conctc.2022.101016 36276262
    [Google Scholar]
  8. Mannucci A. Zuppardo R.A. Rosati R. Leo D.M. Perea J. Cavestro G.M. Colorectal cancer screening from 45 years of age: Thesis, antithesis and synthesis. World J. Gastroenterol. 2019 25 21 2565 2580 31210710
    [Google Scholar]
  9. Santiago-Rodríguez E.J. Rivadeneira N.A. Torres J.M. Sarkar U. Hiatt R.A. Socioeconomic status and colorectal cancer screening behaviors in a vulnerable multiethnic population. Ethn. Health 2022 27 4 980 996 10.1080/13557858.2020.1838454 33121258
    [Google Scholar]
  10. Kobayashi L.C. Wardle J. Wagner V.C. Limited health literacy is a barrier to colorectal cancer screening in England: Evidence from the English Longitudinal Study of Ageing. Prev. Med. 2014 61 100 100 105 10.1016/j.ypmed.2013.11.012 24287122
    [Google Scholar]
  11. Mojica C.M. Lind B. Gu Y. Coronado G.D. Davis M.M. Predictors of colorectal cancer screening modality among newly age-eligible medicaid enrollees. Am. J. Prev. Med. 2021 60 1 72 79 10.1016/j.amepre.2020.08.003 33223363
    [Google Scholar]
  12. Alharbi M. AlSaleem L.S. Alrashid M.H. Alutaibi H. Alabdrabulrida S.A. Mahjari A.A. AlZahrani R. Preferences for colorectal cancer screening modalities among the general population in Saudi Arabia. Cureus 2023 15 3 e36020 10.7759/cureus.36020 37050991
    [Google Scholar]
  13. Makaroff KE Shergill J Lauzon M Khalil C Ahluwalia SC Spiegel BMR Patient preferences for colorectal cancer screening tests in light of lowering the screening age to 45 years. Clin. Gastroenterol. Hepatol 2022 21 2 530 531 10.1016/j.cgh.2022.07.012
    [Google Scholar]
  14. Naber SK Almadi MA Guyatt G Xie F Lansdorp-Vogelaar I Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia. Saudi J. Gastroenterol. 2021 27 4 208 216 10.4103/sjg.sjg_526_20
    [Google Scholar]
  15. Alduraywish S.A. Altamimi L.A. Almajed A.A. Kokandi B.A. Alqahtani R.S. Alghaihb S.G. Aldakheel F.M. Barriers of colorectal cancer screening test among adults in the Saudi population: A cross-sectional study. Prev. Med. Rep. 2020 20 101235 10.1016/j.pmedr.2020.101235 33194537
    [Google Scholar]
  16. Abdulwassi H.K. Al-Hajeili M. Alshadadi F. Alqurashi L. Idriss M. Halawani L. Assessing knowledge on preventive colorectal cancer screening in Saudi Arabia: A cross-sectional study. J. Family Med. Prim. Care 2019 8 10 3140 3146 10.4103/jfmpc.jfmpc_508_19 31742133
    [Google Scholar]
  17. Khoja A. Aljawadi M. Al-Shammari S.A. Bokhari N.N. Aldarwish A.A. Mardini W.K. Khoja T.A. Utilization of colorectal cancer screening among saudi elderly population: A study from the saudi national survey for elderly health. Asian Pac. J. Cancer Prev. 2018 19 12 3401 3407 10.31557/APJCP.2018.19.12.3401 30583346
    [Google Scholar]
  18. Alsanea N. The dilemma of the threshold age to start screening for colorectal cancer in Saudi Arabia. Offic. J. Saudi Gastroenterol. Assoc. 2014 20 141 142 10.4103/1319‑3767.132976
    [Google Scholar]
  19. Alsanea NA The acceptability of screening for colorectal cancer in Saudi Arabia: Myths busted. Saudi J. Gastroenterol. 2015 21 2 59 10.4103/1319‑3767.153806
    [Google Scholar]
  20. Herriges M.J. Shenhav-Goldberg R. Peck J.I. Bhanvadia S.K. Morgans A. Chino F. Chandrasekar T. Shapiro O. Jacob J.M. Basnet A. Bratslavsky G. Goldberg H. Financial toxicity and its association with prostate and colon cancer screening. J. Natl. Compr. Canc. Netw. 2022 20 9 981 988 10.6004/jnccn.2022.7036 36075394
    [Google Scholar]
  21. Noh C.K. Lee E. Park B. Ahn S.S. A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: An analysis of one-million national colorectal cancer screening programme results. BMC Med. 2022 20 1 226 10.1186/s12916‑022‑02416‑y 35786411
    [Google Scholar]
  22. Clark G.R.C. Fraser C.G. Strachan J.A. Steele R.J.C. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme. J. Med. Screen. 2022 29 4 249 254 10.1177/09691413221110012 35747907
    [Google Scholar]
  23. Sarkeala T. Färkkilä M. Anttila A. Hyöty M. Kairaluoma M. Rautio T. Voutilainen M. Helander S. Jäntti M. Lehtinen M. Patrikka L. Malila N. Heinävaara S. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: Population-based registry study from Finland. BMJ Open 2021 11 2 e046667 10.1136/bmjopen‑2020‑046667 33558363
    [Google Scholar]
  24. Peng S.M. Hsu W.F. Wang Y.W. Lin L.J. Yen A.M.F. Chen L.S. Lee Y.C. Wu M.S. Chen T.H.H. Chiu H.M. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Gut 2021 70 7 1318 1324 10.1136/gutjnl‑2020‑320761 32989019
    [Google Scholar]
/content/journals/rrct/10.2174/0115748871335743250417103659
Loading
/content/journals/rrct/10.2174/0115748871335743250417103659
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: screening ; fecal immunochemical test ; Colorectal ; public ; modality ; cancer
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test